Publicaciones en colaboración con investigadoras/es de Universitat de Barcelona (13)

2023

  1. Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism

    Neuropsychopharmacology, Vol. 48, Núm. 2, pp. 341-350

2022

  1. High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers

    International Journal of Neuropsychopharmacology, Vol. 25, Núm. 6, pp. 468-478

2021

  1. Adrenergic Modulation With Photochromic Ligands

    Angewandte Chemie - International Edition, Vol. 60, Núm. 7, pp. 3625-3631

2020

  1. Calcium-binding proteins are altered in the cerebellum in schizophrenia

    PloS one, Vol. 15, Núm. 7, pp. e0230400

2017

  1. The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia

    European Neuropsychopharmacology, Vol. 27, Núm. 2, pp. 180-191

2016

  1. Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia

    Schizophrenia Research, Vol. 177, Núm. 1-3, pp. 88-97

  2. Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia

    Journal of Psychiatry and Neuroscience, Vol. 41, Núm. 3, pp. E46-E55

2015

  1. Transcription factor SP4 phosphorylation is altered in the postmortem cerebellum of bipolar disorder and schizophrenia subjects

    European Neuropsychopharmacology, Vol. 25, Núm. 10, pp. 1650-1660

  2. Transcription factor sp4 regulates expression of nervous wreck 2 to control NMDAR1 levels and dendrite patterning

    Developmental Neurobiology, Vol. 75, Núm. 1, pp. 93-108

2013

  1. Analysis of Sp transcription factors in the postmortem brain of chronic schizophrenia: A pilot study of relationship to negative symptoms

    Journal of Psychiatric Research, Vol. 47, Núm. 7, pp. 926-934

2010

  1. Gi protein coupling to adenosine A1-A2A receptor heteromers in human brain caudate nucleus

    Journal of Neurochemistry, Vol. 114, Núm. 4, pp. 972-980

2009

  1. Immunodensity and mRNA expression of A2A adenosine, D 2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: Effect of antipsychotic treatment

    Psychopharmacology, Vol. 206, Núm. 2, pp. 313-324

2008

  1. Human adenosine deaminase as an allosteric modulator of human A1 adenosine receptor: Abolishment of negative cooperativity for [ 3H](R)-pia binding to the caudate nucleus

    Journal of Neurochemistry, Vol. 107, Núm. 1, pp. 161-170